Cryoport Reports Q1 2026 Earnings with Revenue Growth and Strategic Milestones
Cryoport reported a 16% revenue growth in Q1 2026, driven by strong performance across its Life Sciences Services and Products segments. The company raised full-year revenue guidance to $192 million–$196 million and expects positive adjusted EBITDA in the second half of 2026.
Tickers: $CYRX
Topics: ebitda_improvement market_expansion product_launch revenue_growth